(Q38887384)

7 September 2017

1 reference

title

An overview of circulating cell-free microRNAs as putative biomarkers in Alzheimer's and Parkinson's Diseases (English)

1 reference

7 September 2017

0 references

0 references

1 reference

Meire Silva Batistela

1

1 reference

7 September 2017

Nalini Drieli Josviak

2

1 reference

7 September 2017

Carla Daniela Sulzbach

3

1 reference

7 September 2017

Ricardo Lehtonen Rodrigues de Souza

4

1 reference

7 September 2017

language of work or name

1 reference

6 July 2016

1 reference

International Journal of Neuroscience

7 September 2017

published in

1 reference

7 September 2017

volume

127

1 reference

7 September 2017

issue

6

1 reference

7 September 2017

page(s)

547-558

1 reference

Circulating miRNAs as biomarkers for neurodegenerative disorders.

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Circulating microRNAs: a novel class of potential biomarkers for diagnosing and prognosing central nervous system diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Circulating cell-free microRNA as biomarkers for screening, diagnosis and monitoring of neurodegenerative diseases and other neurologic pathologies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Biomarkers and surrogate endpoints: preferred definitions and conceptual framework

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Biomarkers for neurodegenerative diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

The complexity, function and applications of RNA in circulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Cardio-miRNAs and onco-miRNAs: circulating miRNA-based diagnostics for non-cancerous and cancerous diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Circulating microRNA expression profiles associated with systemic lupus erythematosus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Characterization of extracellular circulating microRNA

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Extracellular miRNAs: the mystery of their origin and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNAs in body fluids--the mix of hormones and biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Phase 1 trial of the oral AKT inhibitor MK-2206 plus carboplatin/paclitaxel, docetaxel, or erlotinib in patients with advanced solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNAs as biomarkers for CNS disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Optimized microRNA purification from TRIzol-treated plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Identification of extracellular miRNA in human cerebrospinal fluid by next-generation sequencing

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Method for microRNA isolation from clinical serum samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Variability in microRNA recovery from plasma: Comparison of five commercial kits.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Extracellular microRNA: a new source of biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Methodological challenges in utilizing miRNAs as circulating biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Clinical relevance of circulating cell-free microRNAs in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Detection of miRNA as non-invasive biomarkers of colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

The microRNA miR-34 modulates ageing and neurodegeneration in Drosophila

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

alpha-Synuclein and neuronal cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Important neuronal toxicity of microtubule-bound Tau in vivo in Drosophila.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Why is the amyloid beta peptide of Alzheimer's disease neurotoxic?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Delivery of siRNA to the mouse brain by systemic injection of targeted exosomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Reduced expression of hsa-miR-27a-3p in CSF of patients with Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNAs in Alzheimer's disease: differential expression in hippocampus and cell-free cerebrospinal fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA-29a Is a Candidate Biomarker for Alzheimer's Disease in Cell-Free Cerebrospinal Fluid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA-135a and -200b, potential Biomarkers for Alzheimer׳s disease, regulate β secretase and amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA Profiling of CSF Reveals Potential Biomarkers to Detect Alzheimer`s Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Profiles of extracellular miRNA in cerebrospinal fluid and serum from patients with Alzheimer's and Parkinson's diseases correlate with disease status and features of pathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Blood serum miRNA: non-invasive biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Circulating miR-125b as a biomarker of Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA in Alzheimer's disease: an exploratory study in brain, cerebrospinal fluid and plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Increased microRNA-34c abundance in Alzheimer's disease circulating blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Identification of blood serum micro-RNAs associated with idiopathic and LRRK2 Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Identification of circulating microRNAs for the differential diagnosis of Parkinson's disease and Multiple System Atrophy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA association with synucleinopathy conversion in rapid eye movement behavior disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Serum microRNA-133b is associated with low ceruloplasmin levels in Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Forecasting the global burden of Alzheimer’s disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Neuropathology of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

CSF Biomarkers for Alzheimer's Disease Diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Identifying and validating biomarkers for Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

CSF biomarkers in neurodegenerative diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Loss of microRNA cluster miR-29a/b-1 in sporadic Alzheimer's disease correlates with increased BACE1/beta-secretase expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Micro-RNA speciation in fetal, adult and Alzheimer's disease hippocampus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Micro-RNA abundance and stability in human brain: specific alterations in Alzheimer's disease temporal lobe neocortex.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

A blood based 12-miRNA signature of Alzheimer disease patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA-206: a potential circulating biomarker candidate for amyotrophic lateral sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Plasma microRNA 210 levels correlate with sensitivity to trastuzumab and tumor presence in breast cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Alzheimer's disease: the amyloid cascade hypothesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Decreased release of the angiogenic peptide vascular endothelial growth factor in Alzheimer's disease: recovering effect with insulin and DHEA sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

An integrated approach for experimental target identification of hypoxia-induced miR-210

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Higher brain BDNF gene expression is associated with slower cognitive decline in older adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Parkinson's disease and parkinsonism: neuropathology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

The role of leucine-rich repeat kinase 2 (LRRK2) in Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Neurodegeneration in Alzheimer's disease: caspases and synaptic element interdependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Aberrant microRNA expression in the brains of neurodegenerative diseases: miR-29a decreased in Alzheimer disease brains targets neurone navigator 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Brain-specific knockdown of miR-29 results in neuronal cell death and ataxia in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

A microRNA-based gene dysregulation pathway in Huntington's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA miR-29c down-regulation leading to de-repression of its target DNA methyltransferase 3a promotes ischemic brain damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Alteration of the microRNA network during the progression of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Variation in the miRNA-433 binding site of FGF20 confers risk for Parkinson disease by overexpression of alpha-synuclein

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Overexpression of miR-128 specifically inhibits the truncated isoform of NTRK3 and upregulates BCL2 in SH-SY5Y neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNAs-10a and -10b contribute to retinoic acid-induced differentiation of neuroblastoma cells and target the alternative splicing regulatory factor SFRS1 (SF2/ASF).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Target gene repression mediated by miRNAs miR-181c and miR-9 both of which are down-regulated by amyloid-β.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Dysregulation of microRNA-219 promotes neurodegeneration through post-transcriptional regulation of tau

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA-101 regulates amyloid precursor protein expression in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

The miR-124 regulates the expression of BACE1/β-secretase correlated with cell death in Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Alternative polyadenylation and miR-34 family members regulate tau expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

A MicroRNA feedback circuit in midbrain dopamine neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Post-transcriptional regulation of alpha-synuclein expression by mir-7 and mir-153

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA-19b-3p Modulates Japanese Encephalitis Virus-Mediated Inflammation via Targeting RNF11

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

On the role of VDAC in apoptosis: fact and fiction

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

miR-132 enhances dendritic morphogenesis, spine density, synaptic integration, and survival of newborn olfactory bulb neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

miR-132/212 knockout mice reveal roles for these miRNAs in regulating cortical synaptic transmission and plasticity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

The role of Nurr1 in the development of dopaminergic neurons and Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA regulation of Alzheimer's Amyloid precursor protein expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Joint genome-wide profiling of miRNA and mRNA expression in Alzheimer's disease cortex reveals altered miRNA regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Sirtuin 1 reduction parallels the accumulation of tau in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Alterations of the microRNA network cause neurodegenerative disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Alpha-synuclein in Lewy bodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Early detection of neurodegenerative diseases: circulating brain-enriched microRNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

MicroRNA-Seq Data Analysis Pipeline to Identify Blood Biomarkers for Alzheimer's Disease from Public Data

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Circulating microRNAs: Association with disease and potential use as biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Plasma microRNA biomarkers for detection of mild cognitive impairment: biomarker validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Testing the right target and right drug at the right stage

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Clinical trials in predementia stages of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Clinical trials and late-stage drug development for Alzheimer's disease: an appraisal from 1984 to 2014

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Detection and Characterization of Placental MicroRNAs in Maternal Plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

Identification of miRNA Changes in Alzheimer's Disease Brain and CSF Yields Putative Biomarkers and Insights into Disease Pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00207454.2016.1209754

10.1080/00207454.2016.1209754

21 January 2018

Identifiers

DOI

1 reference

release_hhpr5mqzqrhhtfjkuj4ud3dtji

7 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/hhpr5mqzqrhhtfjkuj4ud3dtji

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference